If you enjoy this content, please share it with a colleague
RELATED CONTENT
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual American Association of Physicists in Medicine (AAPM) annual meeting, July 14-18 in San Antonio, Texas. The new release of SciMoCa provides what IBA calls the first and only worldwide commercial Monte Carlo Patient QA for the Varian Halcyon System.
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and clinically implemented a novel automated treatment log-based patient quality assurance (QA) approach for proton therapy. This enables them to reduce the time needed for the in-beam measurement-based conventional patient QA.
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (PTCOG) conference, June 10-15 in Manchester, U.K. The company said myQA iON significantly reduces the time needed for patient quality assurance (QA) for proton therapy (PT).
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain and Telemis aimed at accelerating installation, optimizing service and improving clinical operations for proton therapy.
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment room at the University Medical Centre Groningen (UMCG) in The Netherlands. This novel technique has the potential to enhance the therapeutic window with a fast and powerful treatment that delivers a high dose of radiation at an ultra-high dose rate.
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology Center at MedStar Southern Maryland Hospital Center, based on an IBA Dosimetry independent beam scanning solution.
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the first treatment of a patient with proton therapy in Southern Asia.
A few of the big takeaways from the American Society of Radiation Oncology (ASTRO) 2018 meeting in October were industry ...
Interview with Peyman Kabolizadeh, M.D., the medical director of Beaumont Proton Therapy Center, Royal Oak, Mich. He ...
At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria Advisory Committee, a consortium of worldwide radiation therapy experts to help define the future of proton therapy care.